Yang et al. demonstrated ML classifiers combining clinical data, FDG PET/CT metabolic parameters, and RFs to differentiate EGFR wild type, exon 19, and exon 21 mutations in NSCLC [93]. Here, EGFR is linked to non-small cell lung carcinoma.